UNLABELLED: Ten neonates with coxsackie B viral infection presented over a 3-month period. Clinical features included meningoencephalitis, thrombocytopenia, disseminated intravascular coagulopathy, cardiomyopathy, and hepatitis. Eight infants had multiorgan disease, four with severe myocardial dysfunction, of whom two died. All of the infants with severe disease developed symptoms within 7 days of age. In infants presenting within 10 days of birth, in all cases there were symptoms compatible with maternal infection prior to delivery. Severity was associated with perinatal transmission. Enteroviral polymerase chain reaction of CSF, urine, stool or throat swab was positive in nine of the ten babies. Seven of the infants were treated with a 7-day course of the new anti-picornaviral drug pleconaril (5 mg/kg 3 times daily). CONCLUSION: These cases highlight the importance of not missing coxsackie B viral infection in the differential diagnosis of the septic neonate, especially as there is now a potential treatment.
UNLABELLED: Ten neonates with coxsackie B viral infection presented over a 3-month period. Clinical features included meningoencephalitis, thrombocytopenia, disseminated intravascular coagulopathy, cardiomyopathy, and hepatitis. Eight infants had multiorgan disease, four with severe myocardial dysfunction, of whom two died. All of the infants with severe disease developed symptoms within 7 days of age. In infants presenting within 10 days of birth, in all cases there were symptoms compatible with maternal infection prior to delivery. Severity was associated with perinatal transmission. Enteroviral polymerase chain reaction of CSF, urine, stool or throat swab was positive in nine of the ten babies. Seven of the infants were treated with a 7-day course of the new anti-picornaviral drug pleconaril (5 mg/kg 3 times daily). CONCLUSION: These cases highlight the importance of not missing coxsackie B viral infection in the differential diagnosis of the septic neonate, especially as there is now a potential treatment.
Authors: Frederick G Hayden; Darrell T Herrington; Teresa L Coats; Kenneth Kim; Ellen C Cooper; Stephen A Villano; Siyu Liu; Spencer Hudson; Daniel C Pevear; Marc Collett; Mark McKinlay Journal: Clin Infect Dis Date: 2003-06-06 Impact factor: 9.079
Authors: Sebastian Ronellenfitsch; Julia Tabatabai; Sindy Böttcher; Sabine Diedrich; David Frommhold; Susanne Schubert-Bast; Johannes Poeschl; Paul Schnitzler Journal: J Med Case Rep Date: 2014-05-27
Authors: Hans de Graaf; Emanuela Pelosi; Andrea Cooper; John Pappachan; Kim Sykes; Iain MacIntosh; Diane Gbesemete; Tristan W Clark; Sanjay V Patel; Saul N Faust; Marc Tebruegge Journal: Pediatr Infect Dis J Date: 2016-07 Impact factor: 2.129
Authors: Mira Laajala; Minna M Hankaniemi; Juha A E Määttä; Vesa P Hytönen; Olli H Laitinen; Varpu Marjomäki Journal: Viruses Date: 2019-11-28 Impact factor: 5.048